Skip to search formSkip to main contentSkip to account menu

TAK 779

Known as: N-((4-(((6,7-dihydro-2-(4-methylphenyl)-5H-benzocyclohepten-8-yl)carbonyl)amino)phenyl)methyl)tetrahydro-N,N-dimethyl-2H-pyran-4-aminium chloride, TAK-779 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Poster presented at the 7th iMed.ULisboa Postgraduate Students Meeting. Lisbon, 15 July 2015 
2012
2012
BOND, CONSTANCE M. Synthesis of Drug Derivatives Intended for Conjugation to Gold Nanoparticles for the Use in Nanotherapeutics… 
2008
2008
BALLARD, THOMAS ERIC, JR. Small Molecule Control of Biological Function. (Under the direction of Dr. Christian Melander… 
2007
2007
Objective:To improve the synthetic route and synthesize the CCR5 antagonist,TAK-779.Methods:TAK-779 was synthesized via 15 steps… 
2007
2007
HIV combination therapy using protease-inhibitors is associated with elevated plasma levels of atherogenic lipoproteins and…